SPADI — Shoulder Pain and Disability Index
Self-administered shoulder outcome measure (Roach 1991). 5 pain + 8 disability items, each scored 0–10 (NRS). Raw total /130; normalised to 0–100% by dividing by 130 and ×100. Higher = worse. Minimum clinically important difference ≈8 points.
Score interpretation
Pain subscale = pain items / 50 × 100; disability subscale = disability items / 80 × 100. There are no validated severity bands; a change of about 8–13 points is clinically important (Roy 2009).
→ Use to track change over time alongside examination and imaging; manage per the underlying shoulder diagnosis (e.g. BESS rotator cuff guidance).
Interpretation bands for the SPADI. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Methoxyflurane · Inhaled Analgesic — Acute Pain
- Fentanyl Transdermal Patch (Elderly Chronic Pain) · Opioid Analgesic — Transdermal Patch
- Morphine Slow-Release (Elderly Chronic Pain) · Opioid Analgesic — Modified-Release Oral
- Amitriptyline (Neuropathic Pain / Migraine) · Tricyclic Antidepressant / Neuropathic Pain Agent
- Gabapentin · Alpha-2-Delta Ligand — Neuropathic Pain / Epilepsy Adjunct
- Diclofenac (Dysmenorrhoea / Post-gynaecological Procedure) · NSAID — Gynaecological Pain
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.